• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢键和聚合物疏水性对布洛芬在与聚(乙烯基吡咯烷酮)和聚(2-恶唑啉)形成的固体分散体中晶体抑制的相互作用

Mutual Effects of Hydrogen Bonding and Polymer Hydrophobicity on Ibuprofen Crystal Inhibition in Solid Dispersions with Poly(-vinyl pyrrolidone) and Poly(2-oxazolines).

作者信息

Shan Xiaoning, Moghul Maryam A, Williams Adrian C, Khutoryanskiy Vitaliy V

机构信息

Reading School of Pharmacy, University of Reading, Whiteknights, P.O. Box 224, Reading RG6 6AD, UK.

出版信息

Pharmaceutics. 2021 May 4;13(5):659. doi: 10.3390/pharmaceutics13050659.

DOI:10.3390/pharmaceutics13050659
PMID:34064530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8148000/
Abstract

Poly(-vinyl pyrrolidone) (PVP), poly(2-methyl-2-oxazoline) (PMOZ), poly(2-ethyl-2-oxazoline) (PEOZ), poly(2--propyl-2-oxazoline) (PnPOZ), and poly(2-isopropyl-2-oxazoline) (PiPOZ) were used to prepare solid dispersions with ibuprofen (IB), a model poorly-water soluble drug. Dispersions, prepared by solvent evaporation, were investigated using powder X-ray diffractometry, differential scanning calorimetry, and FTIR spectroscopy; hydrogen bonds formed between IB and all polymers in solid dispersions. PMOZ, the most hydrophilic polymer, showed the poorest ability to reduce or inhibit the crystallinity of IB. In contrast, the more hydrophobic polymers PVP, PEOZ, PnPOZ, and PiPOZ provided greater but similar abilities to reduce IB crystallinity, despite the differing polymer hydrophobicity and that PiPOZ is semi-crystalline. These results indicate that crystallinity disruption is predominantly due to hydrogen bonding between the drug molecules and the polymer. However, carrier properties affected drug dissolution, where PnPOZ exhibited lower critical solution temperature that inhibited the release of IB, whereas drug release from other systems was consistent with the degree of ibuprofen crystallinity within the dispersions.

摘要

聚(乙烯基吡咯烷酮)(PVP)、聚(2-甲基-2-恶唑啉)(PMOZ)、聚(2-乙基-2-恶唑啉)(PEOZ)、聚(2-丙基-2-恶唑啉)(PnPOZ)和聚(2-异丙基-2-恶唑啉)(PiPOZ)被用于与布洛芬(IB,一种典型的难溶性药物)制备固体分散体。通过溶剂蒸发法制备的分散体,采用粉末X射线衍射、差示扫描量热法和傅里叶变换红外光谱法进行研究;在固体分散体中,IB与所有聚合物之间均形成了氢键。亲水性最强的聚合物PMOZ,降低或抑制IB结晶度的能力最差。相比之下,疏水性更强的聚合物PVP、PEOZ、PnPOZ和PiPOZ,尽管聚合物疏水性不同且PiPOZ是半结晶的,但它们降低IB结晶度的能力更强且相似。这些结果表明,结晶度的破坏主要是由于药物分子与聚合物之间的氢键作用。然而,载体性质影响药物溶解,其中PnPOZ表现出较低的临界溶解温度,抑制了IB的释放,而其他体系的药物释放与分散体中布洛芬的结晶度程度一致。

相似文献

1
Mutual Effects of Hydrogen Bonding and Polymer Hydrophobicity on Ibuprofen Crystal Inhibition in Solid Dispersions with Poly(-vinyl pyrrolidone) and Poly(2-oxazolines).氢键和聚合物疏水性对布洛芬在与聚(乙烯基吡咯烷酮)和聚(2-恶唑啉)形成的固体分散体中晶体抑制的相互作用
Pharmaceutics. 2021 May 4;13(5):659. doi: 10.3390/pharmaceutics13050659.
2
Polymer structure and property effects on solid dispersions with haloperidol: Poly(N-vinyl pyrrolidone) and poly(2-oxazolines) studies.聚合物结构和性质对氟哌啶醇固体分散体的影响:聚(N-乙烯基吡咯烷酮)和聚(2-恶唑啉)的研究。
Int J Pharm. 2020 Nov 30;590:119884. doi: 10.1016/j.ijpharm.2020.119884. Epub 2020 Sep 18.
3
Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.通过密度泛函理论评估聚乙烯吡咯烷酮(PVP)抑制无定形固体分散体结晶的能力并进行实验验证。
Eur J Pharm Sci. 2017 Jan 1;96:45-52. doi: 10.1016/j.ejps.2016.08.046. Epub 2016 Aug 25.
4
Unravelling the Miscibility of Poly(2-oxazoline)s: A Novel Polymer Class for the Formulation of Amorphous Solid Dispersions.揭开聚(2-恶唑啉)的混溶性之谜:一种用于制备无定形固体分散体的新型聚合物类别。
Molecules. 2020 Aug 6;25(16):3587. doi: 10.3390/molecules25163587.
5
Effects of Molecular Interactions on Miscibility and Mobility of Ibuprofen in Amorphous Solid Dispersions With Various Polymers.分子相互作用对不同聚合物无定形固体分散体中布洛芬相容性和迁移性的影响。
J Pharm Sci. 2019 Jan;108(1):178-186. doi: 10.1016/j.xphs.2018.10.052. Epub 2018 Nov 3.
6
Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.聚(2-乙基-2-恶唑啉)作为聚(乙烯基吡咯烷酮)在固体分散体中的替代物,用于提高药物的溶解度和溶出速率。
J Pharm Sci. 2018 Sep;107(9):2428-2438. doi: 10.1016/j.xphs.2018.05.015. Epub 2018 May 31.
7
Phase behavior of amorphous molecular dispersions II: Role of hydrogen bonding in solid solubility and phase separation kinetics.非晶态分子分散体的相行为II:氢键在固体溶解度和相分离动力学中的作用。
Pharm Res. 2005 Mar;22(3):440-8. doi: 10.1007/s11095-004-1882-y.
8
Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).温度和水分对非晶态硝苯地平分散体与聚维酮混合性的影响。
J Pharm Sci. 2010 Jan;99(1):169-85. doi: 10.1002/jps.21809.
9
Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.无定形固体分散体中氨氯地平的相态行为:均一性和药物-聚合物相互作用。
Mol Pharm. 2019 Dec 2;16(12):4836-4851. doi: 10.1021/acs.molpharmaceut.9b00731. Epub 2019 Nov 4.
10
Optimization and evaluation of resveratrol amorphous solid dispersions with a novel polymeric system.采用新型聚合物系统优化和评价白藜芦醇无定形固体分散体。
Math Biosci Eng. 2022 May 31;19(8):8019-8034. doi: 10.3934/mbe.2022375.

引用本文的文献

1
Microneedles mediated-dermal delivery of Vitamin C: Formulation, characterization, cytotoxicity, and enhancement of stability.微针介导的维生素C经皮给药:制剂、表征、细胞毒性及稳定性增强
Heliyon. 2024 Sep 3;10(17):e37381. doi: 10.1016/j.heliyon.2024.e37381. eCollection 2024 Sep 15.
2
Molecular structure of ketoprofen-polyvinylpyrrolidone solid dispersions prepared by different amorphization methods.通过不同非晶化方法制备的酮洛芬-聚乙烯吡咯烷酮固体分散体的分子结构
RSC Pharm. 2024 Mar 4;1(1):121-131. doi: 10.1039/d3pm00038a. eCollection 2024 Apr 18.
3
The Impact of Various Poly(vinylpyrrolidone) Polymers on the Crystallization Process of Metronidazole.

本文引用的文献

1
Polymer structure and property effects on solid dispersions with haloperidol: Poly(N-vinyl pyrrolidone) and poly(2-oxazolines) studies.聚合物结构和性质对氟哌啶醇固体分散体的影响:聚(N-乙烯基吡咯烷酮)和聚(2-恶唑啉)的研究。
Int J Pharm. 2020 Nov 30;590:119884. doi: 10.1016/j.ijpharm.2020.119884. Epub 2020 Sep 18.
2
Molecular Interactions in Solid Dispersions of Poorly Water-Soluble Drugs.难溶性药物固体分散体中的分子相互作用
Pharmaceutics. 2020 Aug 7;12(8):745. doi: 10.3390/pharmaceutics12080745.
3
Unravelling the Miscibility of Poly(2-oxazoline)s: A Novel Polymer Class for the Formulation of Amorphous Solid Dispersions.
各种聚乙烯吡咯烷酮聚合物对甲硝唑结晶过程的影响。
Pharmaceutics. 2024 Jan 19;16(1):136. doi: 10.3390/pharmaceutics16010136.
4
The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.药物-聚合物相互作用对无定形固体分散体物理稳定性的影响。
Pharm Res. 2023 Dec;40(12):2963-2981. doi: 10.1007/s11095-023-03547-4. Epub 2023 Jun 30.
5
Poly(2-alkyl-2-oxazoline)s: A polymer platform to sustain the release from tablets with a high drug loading.聚(2-烷基-2-恶唑啉):一种用于维持高载药量片剂药物释放的聚合物平台。
Mater Today Bio. 2022 Sep 12;16:100414. doi: 10.1016/j.mtbio.2022.100414. eCollection 2022 Dec.
揭开聚(2-恶唑啉)的混溶性之谜:一种用于制备无定形固体分散体的新型聚合物类别。
Molecules. 2020 Aug 6;25(16):3587. doi: 10.3390/molecules25163587.
4
A Review on Solid Dispersion and Carriers Used Therein for Solubility Enhancement of Poorly Water Soluble Drugs.难溶性药物增溶的固体分散体及其所用载体的综述
Adv Pharm Bull. 2020 Jul;10(3):359-369. doi: 10.34172/apb.2020.044. Epub 2020 May 11.
5
The Use of Poly(-vinyl pyrrolidone) in the Delivery of Drugs: A Review.聚(乙烯基吡咯烷酮)在药物递送中的应用:综述
Polymers (Basel). 2020 May 13;12(5):1114. doi: 10.3390/polym12051114.
6
Insights into the Dissolution Behavior of Ledipasvir-Copovidone Amorphous Solid Dispersions: Role of Drug Loading and Intermolecular Interactions.来普司特-共聚维酮无定形固体分散体的溶解行为研究:载药量和分子间相互作用的作用。
Mol Pharm. 2019 Dec 2;16(12):5054-5067. doi: 10.1021/acs.molpharmaceut.9b01025. Epub 2019 Nov 18.
7
Myth or Truth: The Glass Forming Ability Class III Drugs Will Always Form Single-Phase Homogenous Amorphous Solid Dispersion Formulations.误区还是事实:III类玻璃形成能力药物总是会形成单相均匀无定形固体分散体配方。
Pharmaceutics. 2019 Oct 14;11(10):529. doi: 10.3390/pharmaceutics11100529.
8
Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.聚(2-乙基-2-恶唑啉)作为载体在制备难溶性药物无定形固体分散体中的应用潜力的比较研究。
Eur J Pharm Biopharm. 2019 Nov;144:79-90. doi: 10.1016/j.ejpb.2019.09.005. Epub 2019 Sep 6.
9
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
10
The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity.温度组成相图在热熔挤出制备无定形固体分散体中防止残留结晶度的应用。
Int J Pharm. 2018 Dec 20;553(1-2):454-466. doi: 10.1016/j.ijpharm.2018.10.055. Epub 2018 Oct 25.